TrialCancer medicine2018

Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer.

Daniel Shepshelovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.